Pamela Leckie

511 citations
13 papers · 354 indexed · h-index 7

Pamela Leckie

13 papers receiving 353 citations

Peers

Pamela Leckie
Comparison fields: 5 of 60
  • Hepatology 213
  • Pharmacology 75
  • Dermatology 59
  • Oncology 95
  • Epidemiology 109
Replace Vinod S. Hegade with:
Vinod S. Hegade United Kingdom
Enrico O. Souto United States
Christopher M. Freeman United States
Alejandra Villamil Argentina
De Kai QIU China
Yasumi Katsuta Japan
Françoise Gérard France
Hidesuke Yanagida Japan
K. Patsiaoura Greece
V. Vero Italy
Pamela Leckie relative to Vinod S. Hegade United Kingdom Vinod S. Hegade's profile →
Citations per field
00.5×2.6×
Vinod S. Hegade · 1×
Citations per year

Countries citing papers authored by Pamela Leckie

Since Specialization
Citations

This map shows the geographic impact of Pamela Leckie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Leckie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Leckie more than expected).

Fields of papers citing papers by Pamela Leckie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Leckie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Leckie. The network helps show where Pamela Leckie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Pamela Leckie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pamela Leckie Line = papers co-authored together Pamela Leckie links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20171
2 201527
3 201549
4 2012192
5 20129
6 201213
7 201224
8 20121
9 201232
10 20101
11 20103
12
AUTOTAXIN LEVELS MIRROR EFFICACY OF TREATMENT OF CHOLESTATIC PRURITUS
20101
13
'OUT-PATIENT' ALBUMIN DIALYSIS FOR INTRACTABLE ITCH IN CHRONIC CHOLESTATIC LIVER DISEASE PATIENTS IS A FEASIBLE, SAFE AND EFFICACIOUS ALTERNATIVE TO LIVER TRANSPLANTATION
20091

About Pamela Leckie

Pamela Leckie is a scholar working on Hepatology, Pharmacology and Dermatology, having authored 13 papers that have together received 354 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (6 papers), Organ Transplantation Techniques and Outcomes (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Dermatology and Skin Diseases (2 papers), Liver Diseases and Immunity (2 papers), Cholesterol and Lipid Metabolism (1 paper), Abdominal Surgery and Complications (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Hepatology (213 citations), Pharmacology (75 citations) and Dermatology (59 citations). Pamela Leckie has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Rajiv Jalan, Nathan Davies, Rajeshwar P. Mookerjee, Remco van Dijk, Christian Rust, Ronald P.J. Oude Elferink, Edith M.M. Kuiper, Karel J. van Erpecum, Ulrich Beuers and Henk R. van Buuren. Their work appears in journals such as PLoS ONE, Hepatology and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026